Radial Access for Percutaneous Coronary Intervention Now Dominant Method
By Lori Solomon HealthDay Reporter
THURSDAY, May 16, 2024 -- Use of radial access for percutaneous coronary intervention (PCI) increased 2.8-fold in the United States between 2013 and 2022, according to a study presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions, held from May 2 to 4 in Long Beach, California.
Reza Fazel, M.D., from the Beth Israel Deaconess Medical Center in Brookline, Massachusetts, and colleagues used data from the National Cardiovascular Data Registry CathPCI Registry (roughly 2.24 million procedures; Jan. 1, 2013, through June 30, 2022) to compare the safety of radial versus femoral access for PCI.
The researchers found that during the study period, 61.6 percent of procedures were performed via radial access (increasing from 23.9 percent in 2013 to 68.2 percent in 2022). All geographic regions and the full spectrum of presentations experienced increases, with the largest relative increase seen in patients with ST-segment elevation myocardial infarction. Radial access was significantly associated with lower in-hospital mortality (absolute risk difference [ARD], −0.15 percent), major access site bleeding (ARD, −0.64 percent), and other major vascular complications (ARD, −0.21 percent). However, there was a significantly higher risk for ischemic stroke (ARD, 0.05 percent). No differences were seen for the falsification end point of gastrointestinal or genitourinary bleeding.
"It confirms that the benefit observed for radial access in randomized controlled trials has also been seen in real-world practice, including the largest benefits for the highest-risk patients," Fazel said in a statement.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
In-Hospital Mortality Rare After Percutaneous Coronary Intervention
MONDAY, April 15, 2024 -- In-hospital mortality is rare after percutaneous coronary intervention (PCI) and is most commonly related to prior cardiovascular condition, according to...
CAC Score Predicts MACE in Patients With Stable Chest Pain
THURSDAY, March 14, 2024 -- For people with stable chest pain referred for invasive coronary angiography (ICA), the risk for major adverse cardiovascular events (MACE) is low...
Ultrahigh Spatial-Resolution PCD CT Improves Assessment of Calcified Stenoses
TUESDAY, Feb. 27, 2024 -- Use of ultrahigh spatial-resolution photon-counting detector (PCD) computed tomography (CT) improves in vivo and in vitro coronary stenosis assessment...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.